Evaluation of ABSOLVE in Diabetic Foot Ulcers

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

August 15, 2017

Study Completion Date

October 15, 2017

Conditions
Diabetic Foot Ulcers
Interventions
DRUG

RhPDGF-BB

One 2x4x.3cm of collagen wound matrix is saturated with 2.0 ml of the rhPDGF-BB solution.

OTHER

Placebo

Collagen Wound Dressing wetted with buffer.

Trial Locations (1)

010116

RECRUITING

Centro Medico Militar, Guatemala City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medelis Inc.

INDUSTRY

collaborator

Centro Medico Militar

UNKNOWN

lead

Lynch Biologics LLC

INDUSTRY

NCT03037970 - Evaluation of ABSOLVE in Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter